193 related articles for article (PubMed ID: 28733034)
1. Decreased expression of miR-150, miR146a and miR424 in type 1 diabetic patients: Association with ongoing islet autoimmunity.
Wang G; Gu Y; Xu N; Zhang M; Yang T
Biochem Biophys Res Commun; 2018 Apr; 498(3):382-387. PubMed ID: 28733034
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of microRNA miR-326 in type 1 diabetic patients with ongoing islet autoimmunity.
Sebastiani G; Grieco FA; Spagnuolo I; Galleri L; Cataldo D; Dotta F
Diabetes Metab Res Rev; 2011 Nov; 27(8):862-6. PubMed ID: 22069274
[TBL] [Abstract][Full Text] [Related]
3. Increased Expression of Circulating microRNA 101-3p in Type 1 Diabetes Patients: New Insights Into miRNA-Regulated Pathophysiological Pathways for Type 1 Diabetes.
Santos AS; Cunha Neto E; Fukui RT; Ferreira LRP; Silva MER
Front Immunol; 2019; 10():1637. PubMed ID: 31396209
[TBL] [Abstract][Full Text] [Related]
4. Decreased miR-146 expression in peripheral blood mononuclear cells is correlated with ongoing islet autoimmunity in type 1 diabetes patients 1miR-146.
Yang M; Ye L; Wang B; Gao J; Liu R; Hong J; Wang W; Gu W; Ning G
J Diabetes; 2015 Mar; 7(2):158-65. PubMed ID: 24796653
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs miR-21a and miR-93 are down regulated in peripheral blood mononuclear cells (PBMCs) from patients with type 1 diabetes.
Salas-Pérez F; Codner E; Valencia E; Pizarro C; Carrasco E; Pérez-Bravo F
Immunobiology; 2013 May; 218(5):733-7. PubMed ID: 22999472
[TBL] [Abstract][Full Text] [Related]
6. microRNA-143-3p contributes to inflammatory reactions by targeting FOSL2 in PBMCs from patients with autoimmune diabetes mellitus.
Pan S; Li M; Yu H; Xie Z; Li X; Duan X; Huang G; Zhou Z
Acta Diabetol; 2021 Jan; 58(1):63-72. PubMed ID: 32815005
[TBL] [Abstract][Full Text] [Related]
7. Identifying common and specific microRNAs expressed in peripheral blood mononuclear cell of type 1, type 2, and gestational diabetes mellitus patients.
Collares CV; Evangelista AF; Xavier DJ; Rassi DM; Arns T; Foss-Freitas MC; Foss MC; Puthier D; Sakamoto-Hojo ET; Passos GA; Donadi EA
BMC Res Notes; 2013 Nov; 6():491. PubMed ID: 24279768
[TBL] [Abstract][Full Text] [Related]
8. miR-487a-3p upregulated in type 1 diabetes targets CTLA4 and FOXO3.
Zurawek M; Dzikiewicz-Krawczyk A; Izykowska K; Ziolkowska-Suchanek I; Skowronska B; Czainska M; Podralska M; Fichna P; Przybylski G; Fichna M; Nowak J
Diabetes Res Clin Pract; 2018 Aug; 142():146-153. PubMed ID: 29859273
[TBL] [Abstract][Full Text] [Related]
9. [Expression of miR-22 and miR-150 in type 1 diabetes mellitus: Possible relationship with autoimmunity and clinical characteristics].
Estrella S; Garcia-Diaz DF; Codner E; Camacho-Guillén P; Pérez-Bravo F
Med Clin (Barc); 2016 Sep; 147(6):245-7. PubMed ID: 27377214
[TBL] [Abstract][Full Text] [Related]
10. Pancreas-enriched miRNAs are altered in the circulation of subjects with diabetes: a pilot cross-sectional study.
Seyhan AA; Nunez Lopez YO; Xie H; Yi F; Mathews C; Pasarica M; Pratley RE
Sci Rep; 2016 Aug; 6():31479. PubMed ID: 27558530
[TBL] [Abstract][Full Text] [Related]
11. Expression Pattern of microRNAs, miR-21, miR-155 and miR-338 in Patients with Type 1 Diabetes.
Mostahfezian M; Azhir Z; Dehghanian F; Hojati Z
Arch Med Res; 2019 Apr; 50(3):79-85. PubMed ID: 31495393
[TBL] [Abstract][Full Text] [Related]
12. Association of serum microRNAs with islet autoimmunity, disease progression and metabolic impairment in relatives at risk of type 1 diabetes.
Snowhite IV; Allende G; Sosenko J; Pastori RL; Messinger Cayetano S; Pugliese A
Diabetologia; 2017 Aug; 60(8):1409-1422. PubMed ID: 28500393
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of microRNAs, miR-20a and miR-326 in PBMCs of patients with type 1 diabetes.
Azhir Z; Dehghanian F; Hojati Z
Mol Biol Rep; 2018 Dec; 45(6):1973-1980. PubMed ID: 30194557
[TBL] [Abstract][Full Text] [Related]
14. Altered Expression of Vitamin D Metabolism Genes and Circulating MicroRNAs in PBMCs of Patients with Type 1 Diabetes: Their Association with Vitamin D Status and Ongoing Islet Autoimmunity.
Al-Nakhle H; Mohsen I; Elnaem B; Alharbi A; Alnakhli I; Almoarfi S; Fallatah J
Noncoding RNA; 2023 Oct; 9(5):. PubMed ID: 37888206
[TBL] [Abstract][Full Text] [Related]
15. miR15a and miR16 in Chilean type 1 diabetes patients: possible association with apoptosis, inflammatory, or autoimmunity markers.
Garcia-Diaz DF; Camacho-Guillén P; Codner E; Pérez-Bravo F
J Endocrinol Invest; 2018 Sep; 41(9):1083-1088. PubMed ID: 29383679
[TBL] [Abstract][Full Text] [Related]
16. Circulating microRNA levels predict residual beta cell function and glycaemic control in children with type 1 diabetes mellitus.
Samandari N; Mirza AH; Nielsen LB; Kaur S; Hougaard P; Fredheim S; Mortensen HB; Pociot F
Diabetologia; 2017 Feb; 60(2):354-363. PubMed ID: 27866223
[TBL] [Abstract][Full Text] [Related]
17. The aberrant expression of microRNAs and correlations with T cell subsets in patients with immune thrombocytopenia.
Liu L; Hua M; Liu C; He N; Li Z; Ma D
Oncotarget; 2016 Nov; 7(47):76453-76463. PubMed ID: 27802180
[TBL] [Abstract][Full Text] [Related]
18. Decreased Serum
Liu Y; Ma M; Yu J; Ping F; Zhang H; Li W; Xu L; Li Y
Int J Endocrinol; 2019; 2019():8406438. PubMed ID: 31582977
[TBL] [Abstract][Full Text] [Related]
19. Expression of miR-155, miR-146a, and miR-326 in T1D patients from Chile: relationship with autoimmunity and inflammatory markers.
García-Díaz DF; Pizarro C; Camacho-Guillén P; Codner E; Soto N; Pérez-Bravo F
Arch Endocrinol Metab; 2018 Feb; 62(1):34-40. PubMed ID: 29694627
[TBL] [Abstract][Full Text] [Related]
20. Dysregulated Serum MiRNA Profile and Promising Biomarkers in Dengue-infected Patients.
Ouyang X; Jiang X; Gu D; Zhang Y; Kong SK; Jiang C; Xie W
Int J Med Sci; 2016; 13(3):195-205. PubMed ID: 26941580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
